Atlas Trials

Stereotactic Body Radiation Therapy, Tremelimumab and Durvalumab in Treating Participants With Recurrent or Metastatic Cervical, Vaginal, or Vulvar Cancers

Clinical trial NCT03452332 · COMPLETED

Trial details

NCT number
NCT03452332
Sponsor
M.D. Anderson Cancer Center
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Advanced Cervical AdenocarcinomaAdvanced Vaginal CarcinomaAdvanced Vulvar CarcinomaHuman Papillomavirus-Related Cervical Squamous Cell CarcinomaHuman Papillomavirus-Related Vulvar Squamous Cell CarcinomaMetastatic Cervical AdenocarcinomaMetastatic Cervical CarcinomaMetastatic Cervical Squamous Cell Carcinoma, Not Otherwise SpecifiedMetastatic Vaginal AdenocarcinomaMetastatic Vaginal CarcinomaMetastatic Vulvar CarcinomaRecurrent Cervical Adenocarcinoma
Start date
2018-07-18
Primary completion
2023-08-11
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.